IL1B and necrotizing enterocolitis: Similarly, neonatal treatment with Lactobacillus reuteri DSM 17938 reduces intestinal levels of IL-1β plus IFN-γ, diminishes NEC occurrence, stimulates gut CD4+ T cells and elevates FoxP3+ regulatory T cells [150].